Literature DB >> 22581143

Superior recovery profiles of propofol-based regimen as compared to isoflurane-based regimen in patients undergoing craniotomy for primary brain tumor excision: a retrospective study.

Yoshihide Miura1, Kouhei Kamiya, Kaoru Kanazawa, Masayuki Okada, Masaki Nakane, Airi Kumasaka, Kaneyuki Kawamae.   

Abstract

PURPOSE: Studies comparing the recovery profiles of isoflurane- and propofol-based anesthesia for major intracranial surgery have reported contradictory results. The aim of our study was to clarify the emergence status in both regimens by investigating uniformly managed neuroanesthesia cases.
METHODS: The anesthesia database at Yamagata University Hospital covering the period 2002-2005 was retrospectively investigated for adult patients who underwent craniotomy for primary brain tumor excision. General anesthesia was provided by an isoflurane- (ISO group) or propofol-based (PROP group) regimen. Times to extubation and operating room (OR) discharge, perioperative consciousness levels, and perioperative variables were compared.
RESULTS: Of the 202 surgeries performed during the study period, 77 and 82 patients were anesthetized with isoflurane and propofol, respectively. Demographic data were comparable between the two groups, although the American Society of Anesthesiology grade was worse in the PROP group. Extubation times [39.5 ± 14.6 min (ISO) vs. 29.5 ± 14.9 min (PROP); P < 0.001] and OR discharge times [67.2 ± 18.0 (ISO) vs. 53.9 ± 17.6 min (PROP); P < 0.001] were significantly shorter in the PROP, with significantly better immediate consciousness levels. The differences in levels of consciousness persisted for several hours postoperatively. PROP patients had significantly higher urine outputs and lower body temperatures during anesthesia. The incidences of shivering, nausea, vomiting, and convulsions were not significantly different between the groups. The time to discharge was similar between the groups.
CONCLUSIONS: Propofol was associated with a better recovery profile and neurological condition than isoflurane, as indicated by shorter extubation and OR discharge times and better postoperative consciousness.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581143     DOI: 10.1007/s00540-012-1398-2

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  13 in total

1.  A comparison of frontal and occipital bispectral index values obtained during neurosurgical procedures.

Authors:  Toshie Shiraishi; Hiroyuki Uchino; Takeshi Sagara; Nagao Ishii
Journal:  Anesth Analg       Date:  2004-06       Impact factor: 5.108

2.  Influence of halothane, enflurane, and isoflurane on motor evoked potentials.

Authors:  J Zentner; T Albrecht; D Heuser
Journal:  Neurosurgery       Date:  1992-08       Impact factor: 4.654

Review 3.  Total intravenous anesthesia: advantages for intracranial surgery.

Authors:  Chad D Cole; Oren N Gottfried; Dhanesh K Gupta; William T Couldwell
Journal:  Neurosurgery       Date:  2007-11       Impact factor: 4.654

4.  Sevoflurane provides faster recovery and postoperative neurological assessment than isoflurane in long-duration neurosurgical cases.

Authors:  Alain Gauthier; Francois Girard; Daniel Boudreault; Monique Ruel; Alexandre Todorov
Journal:  Anesth Analg       Date:  2002-11       Impact factor: 5.108

5.  The cerebral metabolic effects of isoflurane at and above concentrations that suppress cortical electrical activity.

Authors:  L A Newberg; J H Milde; J D Michenfelder
Journal:  Anesthesiology       Date:  1983-07       Impact factor: 7.892

Review 6.  Inhalational or intravenous anesthetics for craniotomies? Pro inhalational.

Authors:  Kristin Engelhard; Christian Werner
Journal:  Curr Opin Anaesthesiol       Date:  2006-10       Impact factor: 2.706

7.  Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial space-occupying lesions.

Authors:  J Guy; B J Hindman; K Z Baker; C O Borel; M Maktabi; N Ostapkovich; J Kirchner; M M Todd; P Fogarty-Mack; V Yancy; M D Sokoll; A McAllister; C Roland; W L Young; D S Warner
Journal:  Anesthesiology       Date:  1997-03       Impact factor: 7.892

8.  Vital organ blood flow during deliberate hypotension in dogs.

Authors:  O Kick; H Van Aken; P F Wouters; K Verbesselt; J Van Hemelrijck
Journal:  Anesth Analg       Date:  1993-10       Impact factor: 5.108

9.  A comparison of three anesthetic techniques in patients undergoing craniotomy for supratentorial intracranial surgery.

Authors:  Pekka Talke; James E Caldwell; Ronald Brown; Barbara Dodson; Joan Howley; Charles A Richardson
Journal:  Anesth Analg       Date:  2002-08       Impact factor: 5.108

10.  A prospective, comparative trial of three anesthetics for elective supratentorial craniotomy. Propofol/fentanyl, isoflurane/nitrous oxide, and fentanyl/nitrous oxide.

Authors:  M M Todd; D S Warner; M D Sokoll; M A Maktabi; B J Hindman; F L Scamman; J Kirschner
Journal:  Anesthesiology       Date:  1993-06       Impact factor: 7.892

View more
  6 in total

1.  Extubation time in neurosurgical patients: does it matter?

Authors:  Tumul Chowdhury; Ronald B Cappellani
Journal:  J Anesth       Date:  2013-04-16       Impact factor: 2.078

2.  In reply: Superior recovery profiles of propofol-based regimen as compared to isoflurane-based regimen in patients undergoing craniotomy for primary brain tumor excision: a retrospective study.

Authors:  Yoshihide Miura
Journal:  J Anesth       Date:  2013-04-11       Impact factor: 2.078

3.  Effects of Moderate Hyperventilation on Jugular Bulb Gases under Propofol or Isoflurane Anesthesia during Supratentorial Craniotomy.

Authors:  Lan Meng; Shu-Qin Li; Nan Ji; Fang Luo
Journal:  Chin Med J (Engl)       Date:  2015-05-20       Impact factor: 2.628

Review 4.  Principles of neuroanesthesia in aneurysmal subarachnoid hemorrhage.

Authors:  Sandeep Kundra; Vidhi Mahendru; Vishnu Gupta; Ashwani Kumar Choudhary
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-07

5.  Anesthetic effects of isoflurane and the molecular mechanism underlying isoflurane‑inhibited aggressiveness of hepatic carcinoma.

Authors:  Jing Hu; Jingli Hu; Hongmei Jiao; Qingguo Li
Journal:  Mol Med Rep       Date:  2018-05-02       Impact factor: 2.952

6.  Streamlining brain tumor surgery care during the COVID-19 pandemic: A case-control study.

Authors:  Regin Jay Mallari; Michael B Avery; Alex Corlin; Amalia Eisenberg; Terese C Hammond; Neil A Martin; Garni Barkhoudarian; Daniel F Kelly
Journal:  PLoS One       Date:  2021-07-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.